136 related articles for article (PubMed ID: 29344179)
1.
Si C; Xu M; Lu M; Yu Y; Yang M; Yan M; Zhou L; Yang X
Oncol Lett; 2017 Dec; 14(6):7391-7397. PubMed ID: 29344179
[TBL] [Abstract][Full Text] [Related]
2. Assessment of in vivo anti-tumor activity of human umbilical vein endothelial cell vaccines prepared by various antigen forms.
Zhou L; Si C; Li D; Lu M; Zhong W; Xie Z; Guo L; Zhang S; Xu M
Eur J Pharm Sci; 2018 Mar; 114():228-237. PubMed ID: 29277666
[TBL] [Abstract][Full Text] [Related]
3. A Fixed Human Umbilical Vein Endothelial Cell Vaccine With 2 Tandem Repeats of Microbial HSP70 Peptide Epitope 407-426 As Adjuvant for Therapy of Hepatoma in Mice.
Xu M; Zhou L; Zhang Y; Xie Z; Zhang J; Guo L; Wang C; Yang X
J Immunother; 2015 Sep; 38(7):276-84. PubMed ID: 26261891
[TBL] [Abstract][Full Text] [Related]
4. Enhanced antitumor efficacy by combination treatment with a human umbilical vein endothelial cell vaccine and a tumor cell lysate-based vaccine.
Xu M; Zhou L; Zhang P; Lu Y; Ge C; Yao W; Xing Y; Xiao W; Dong Y; Wu J; Cao R; Li T
Tumour Biol; 2013 Oct; 34(5):3173-82. PubMed ID: 23771850
[TBL] [Abstract][Full Text] [Related]
5. Protective antitumor immunity induced by tumor cell lysates conjugated with diphtheria toxin and adjuvant epitope in mouse breast tumor models.
Wang ZY; Xing Y; Liu B; Lu L; Huang X; Ge CY; Yao WJ; Xu ML; Gao ZQ; Cao RY; Wu J; Li TM; Liu JJ
Chin J Cancer; 2012 Jun; 31(6):295-305. PubMed ID: 22464650
[TBL] [Abstract][Full Text] [Related]
6. Enhanced antitumor immunity by targeting dendritic cells with tumor cell lysate-loaded chitosan nanoparticles vaccine.
Shi GN; Zhang CN; Xu R; Niu JF; Song HJ; Zhang XY; Wang WW; Wang YM; Li C; Wei XQ; Kong DL
Biomaterials; 2017 Jan; 113():191-202. PubMed ID: 27816821
[TBL] [Abstract][Full Text] [Related]
7. [Application of a tumor cell vaccine transfected with GM-CSF/IL-2 fusion gene for specific immunotherapy of hepatocellular carcinoma].
Guo C; Liu QG; Yang W; Yao YM
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb; 28(2):188-92. PubMed ID: 18250039
[TBL] [Abstract][Full Text] [Related]
8. Antitumor immunopreventive and immunotherapeutic effect in mice induced by hybrid vaccine of dendritic cells and hepatocarcinoma in vivo.
Zhang JK; Li J; Zhang J; Chen HB; Chen SB
World J Gastroenterol; 2003 Mar; 9(3):479-84. PubMed ID: 12632501
[TBL] [Abstract][Full Text] [Related]
9. Anti-tumor immunity elicited by cross-linking vaccine heat shock protein 72 and alpha-fetoprotein epitope peptide.
Li Z; Wang XP; Lin HP; Xu B; Zhao Q; Qi BN; Yang YX; Wang ZR
Neoplasma; 2015; 62(5):713-21. PubMed ID: 26278150
[TBL] [Abstract][Full Text] [Related]
10. Effects of tumor-specific antigen induced by lentinan on murine H22 hepatocellular carcinoma immunoprophylaxis.
Wang Y; Han X; Li YD; Zhao SY; Zhang DJ; Zhao ZH; Wang YB
Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4516-24. PubMed ID: 26698247
[TBL] [Abstract][Full Text] [Related]
11. [Antitumor effect of immunizations with fusions of dendritic and hepatocellular carcinoma cells in mice].
Zhang H; Zheng SS; Jiang GP; Zhou L; Xie HY
Zhonghua Gan Zang Bing Za Zhi; 2004 Nov; 12(11):648-51. PubMed ID: 15623369
[TBL] [Abstract][Full Text] [Related]
12. Anti-Tumor Activity of Mannose-CpG-Oligodeoxynucleotides-Conjugated and Hepatoma Lysate-Loaded Nanoliposomes for Targeting Dendritic Cells
Yang X; Lai C; Liu A; Hou X; Tang Z; Mo F; Yin S; Lu X
J Biomed Nanotechnol; 2019 May; 15(5):1018-1032. PubMed ID: 30890232
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cells loaded with the lysate of tumor cells infected with Newcastle Disease Virus trigger potent anti-tumor immunity by promoting the secretion of IFN-γ and IL-2 from T cells.
Zhao L; Niu C; Shi X; Xu D; Li M; Cui J; Li W; Xu J; Jin H
Oncol Lett; 2018 Jul; 16(1):1180-1188. PubMed ID: 30061941
[TBL] [Abstract][Full Text] [Related]
14. Experimental study on therapeutic effect of in vivo expression of Cell I-Hep II recombinant polypeptide of fibronectin on murine H22 hepatocellular carcinoma.
Zhang GM; Yang Y; Huang B; Xiao H; Li D; Feng ZH
World J Gastroenterol; 2003 Sep; 9(9):1940-5. PubMed ID: 12970880
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of antitumor effects of dendritic cells modified with different forms of hepatocellular cancer antigens].
He LX; Zhang GM; Feng ZH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jan; 21(1):100-2, 117. PubMed ID: 15629095
[TBL] [Abstract][Full Text] [Related]
16. Comparison of tumor-derived total RNA and cell lysate on antitumor immune activity.
Chen Q; Jin Y; Li X; Zhang P; Pan W; Zhang D; Lin D; Chen W; Lin J
Biomed Pharmacother; 2023 Apr; 160():114377. PubMed ID: 36764134
[TBL] [Abstract][Full Text] [Related]
17. [Application of fusion gene mGM-CSF/hIL-2 to specific immunotherapy induced by hepatic tumor cell vaccine].
Yang W; Guo C; Liu QG
Ai Zheng; 2008 Feb; 27(2):149-54. PubMed ID: 18279611
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic cancer immunotherapy using a tumor lysate vaccine, engineered to express α-gal epitopes, targets pancreatic cancer stem cells.
Tanida T; Tanemura M; Miyoshi E; Nagano H; Furukawa K; Nonaka Y; Akita H; Hama N; Wada H; Kawamoto K; Kobayashi S; Eguchi H; Mori M; Doki Y
Int J Oncol; 2015 Jan; 46(1):78-90. PubMed ID: 25354268
[TBL] [Abstract][Full Text] [Related]
19. Two tandem repeats of mHSP70
Xu M; Zhang Y; Dong W; Jiang L; Zhang J; Yu P; Xie S; Zhou L
Life Sci; 2018 May; 201():102-110. PubMed ID: 29572180
[TBL] [Abstract][Full Text] [Related]
20. Immunizing effects of cocultures of H22 hepatocarcinoma cells and cartilage polysaccharide on murine H22 hepatocarcinoma.
Han X; Liu AJ; Zhao XH; Li YD; Zheng GQ; Zhang GR
J Food Sci; 2010 Oct; 75(8):H265-73. PubMed ID: 21535505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
